Projects and Publications

Gyurkocza B, et al. Randomized phase III SIERRA trial of 131I-apamistamab before allogeneic hematopoietic cell transplantation vs conventional care for relapsed/refractory acute myeloid leukemia. Journal of Clinical Oncology 2024

Muangnoicharoen S, et al. Heterologous Ad26.COV2.S booster after primary BBIBP-CorV vaccination against SARS-CoV-2 infection: 1-year follow-up of a phase 1/2 open-label trial. Vaccine 2024

Stieh DJ, et al. Safety and immunogenicity of Ad26-vectored HIV vaccine with mosaic immunogens and a novel mosaic envelope protein in HIV-Uninfected adults: a phase 1/2a study. Journal of Infectious Diseases 2023

Lee JM, et al Surgical perspective on neoadjuvant immunotherapy in non-small cell lung cancer. Annals of Thoracic Surgery 2022

Felip E, et al. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial. The Lancet 2021

Finn RS, et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. New England Journal of Medicine 2020

Kashmar M, … Santangelo S, et al. Consensus opinions on facial beauty and implications for aesthetic treatment in Middle Eastern women. Plastic and Reconstructive Surgery – Global Open 2019

Goodman GJ, … Santangelo S, et al. Impact of smoking and alcohol use on facial ageing in women: results of a large multinational, multiracial, cross-sectional survey. Journal of Clinical and Aesthetic Dermatology 2019

Barrett A, Santangelo S, et al. Breast cancer associated transcriptional repressor PLU-1/JARID1B interacts directly with histone deacetylases. International Journal of Cancer 2007

Santangelo S, et al. DNA demethylation correlates with DNase I hypersensitive site formation during human CD4+ T cell differentiation. Journal of Immunology 2002